Today is Thursday, July 25, 2019 and here’s your daily small cap valuation.
Apyx Medical Corporation (NASDAQ: APYX) is a small-cap stock that could have a lot of potential. But it’s hard to value smaller companies like this. Conventional valuation metrics like price-to-earnings (P/E) ratio, profit margin, and return on equity (ROE) may not be available for them.
Editor’s Note: We’ve been keeping an eye on a set of small-cap stocks that are a better value than Apyx Medical Corporation. These stocks have the potential for bigger gains — and they’re far less risky than the speculative small caps many investors gamble on. Enter your email below to learn more.
To get a sense of Apyx Medical Corporation’s true valuation, let’s compare it to its industry peers — and to itself one year ago. We’ll look at four small cap valuation metrics…
Price-to-Book Value (P/B) Ratio
Apyx Medical Corporation’s price-to-book value (P/B) ratio of 2.741 is 46.19% lower than its industry average of 5.094. That’s good. A low P/B ratio indicates that the company has a solid balance sheet — and that based on its balance sheet, the stock is trading for unusually cheap.
Free Cash Flow Yield (FCF/Enterprise Value)
Apyx Medical Corporation’s free cash flow yield (FCF/EV) of -16.00% is 1276.47% lower than its industry average of 1.36%. That’s not good. This metric compares free cash flow (the amount of cash left over after all expenses and capital expenditures have been paid) with enterprise value (a comprehensive alternative to market cap that includes cash and debt).
A low free cash flow yield indicates that a company is performing inefficiently — or that it’s struggling with the debt on its books.
Earnings per Share (EPS) Growth
Apyx Medical Corporation has grown its earnings per share (EPS) by 1321.43% in the last year. That’s good. Many smaller, newer companies have negative earnings for a few years, but that’s okay as long as earnings are going up over time.
Gross Margin Growth
Apyx Medical Corporation has not grown its gross margin in the last year. That’s not good. It indicates that the company is making less money from its operations over time.
Apyx Medical Corporation scored favorably on 2 of our 4 valuation metrics. With this in mind, we believe the stock is appropriately valued.
Got another small-cap stock you want us to test with our valuation metrics? Leave the ticker symbol in the comments below.